C
Christian Kranjec
Researcher at Norwegian University of Life Sciences
Publications - 5
Citations - 129
Christian Kranjec is an academic researcher from Norwegian University of Life Sciences. The author has contributed to research in topics: Staphylococcus aureus & Antimicrobial. The author has an hindex of 3, co-authored 5 publications receiving 35 citations.
Papers
More filters
Journal ArticleDOI
Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives.
Christian Kranjec,Danae Morales Angeles,Marita Torrissen Mårli,Lucía Fernández,Lucía Fernández,Pilar García,Pilar García,Morten Kjos,Dzung B. Diep +8 more
TL;DR: In this paper, the authors provide an overview of current knowledge of the stages of biofilm development and what difficulties may arise when trying to eradicate staphylococcal biofilms.
Journal ArticleDOI
Successful Development of Bacteriocins into Therapeutic Formulation for Treatment of MRSA Skin Infection in a Murine Model.
TL;DR: Two broad-spectrum bacteriocins acted synergistically with each other and with penicillin G in killing MRSA in vitro, demonstrating that the three-component formulation was efficient in eradicating the pathogen from treated wounds.
Journal ArticleDOI
A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms
Christian Kranjec,Kirill V. Ovchinnikov,Torstein Grønseth,Torstein Grønseth,Kumar Ebineshan,Aparna Srikantam,Dzung B. Diep +6 more
TL;DR: It is shown that a combination of two bacteriocins with distinct structural and functional characteristics, garvicin KS, and micrococcin P1, showed a synergetic antibacterial activity against biofilms produced in vitro by S. aureus, including several MRSA strains.
Journal ArticleDOI
A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms
Christian Kranjec,Sofie S. Kristensen,Karolina T. Bartkiewicz,Mikkel Brønner,Jorunn Pauline Cavanagh,Aparna Srikantam,Geir Mathiesen,Dzung B. Diep +7 more
TL;DR: In this paper, a novel hybrid bacteriocin, Hybrid 1 (H1), was designed by combing the Nterminal part and the C-terminal parts of the related bacterioinocin K1 (K1) and EJ97 (EJ97), respectively.
Journal ArticleDOI
A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model.
Kirill V. Ovchinnikov,Christian Kranjec,Amar Telke,Morten Kjos,Tage Thorstensen,Siegfried Scherer,Harald Carlsen,Dzung B. Diep +7 more
TL;DR: In this paper, the authors identified a strain of Staphylococcus equorum producing a substance with high antimicrobial activity against many Gram-positive bacteria, including MRSA.